Author

admin

Browsing

Sun Summit Minerals Corp. (TSXV: SMN,OTC:SMREF) (OTCQB: SMREF) (‘Sun Summit’ or the ‘Company’) is pleased to announce that it will be attending and presenting at the 51st Annual New Orleans Investment Conference, taking place November 2–5, 2025 at the Hilton New Orleans Riverside.

Niel Marotta, CEO and Director, will host a Sunrise Session presentation on Tuesday, November 4 at 7:15 AM (Churchill B2), where he will share updates on the Company’s flagship JD Project in British Columbia’s Toodoggone District, following the completion of a successful 2025 exploration season.

Space is limited. Investors are invited to RSVP by October 31 to info@sunsummitminerals.com, and to visit Sun Summit at Booth #229 throughout the conference.

The New Orleans Investment Conference brings together leading analysts, newsletter writers, and investors to discuss emerging opportunities across all major asset classes. Register today at https://neworleansconference.com/online-registration/.

About the JD Project

The JD Project is located in the Toodoggone mining district in north-central British Columbia, a highly prospective deposit-rich mineral trend. The project covers an area of over 15,000 hectares and is in close proximity to active exploration and development projects, such as Thesis Gold’s Lawyers and Ranch projects, TDG Gold’s Baker-Shasta projects, Amarc Resource’s AuRORA project, Centerra’s Gold’s Kemess East and Underground projects, as well as the past-producing Kemess open pit copper-gold mine.

The project is 450 kilometres northwest of the city of Prince George, and 25 kilometres north of the Sturdee airstrip. It is proximal to existing infrastructure in place to support the past-producing Kemess mine, including roads and a hydroelectric power line.

The JD Project is in a favourable geological environment characterized by both high-grade epithermal gold and silver mineralization, as well as porphyry-related copper and gold mineralization. Some historical exploration, including drilling, geochemistry and geophysics, has been carried out on the property, however the project area is largely underexplored.

About Sun Summit

Sun Summit Minerals (TSXV: SMN,OTC:SMREF) (OTCQB: SMREF) is a mineral exploration company focused on the discovery, expansion and advancement of district-scale gold and copper assets in British Columbia. The Company’s diverse portfolio includes its flagship JD Project and the nearby Theory Project in the Toodoggone region of north-central B.C., as well as the Buck Project in central B.C.

Further details are available at www.sunsummitminerals.com.

On behalf of the board of directors

Niel Marotta
Chief Executive Officer & Director
info@sunsummitminerals.com

For further information, contact:

Matthew Benedetto, Simone Capital
mbenedetto@simonecapital.ca
Tel. 416-817-1226

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Statements contained in this news release that are not historical in nature may be ‘forward-looking information’ within the meaning of applicable Canadian securities legislation (‘forward-looking statements ‘), which involve risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements, by their nature, require Sun Summit to make certain assumptions and necessarily involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in these forward-looking statements. Forward-looking statements are not guarantees of performance. Words such as ‘may’, ‘will’, ‘would’, ‘could’, ‘expect’, ‘believe’, ‘plan’, ‘anticipate’, ‘intend’, ‘estimate’, ‘continue’, ‘objective’, ‘strategy’, or the negative or comparable terminology, as well as terms usually used in the future and the conditional, are intended to identify forward-looking statements. Information contained in forward-looking statements is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including the assumptions, qualifications, limitations or statements relating to the pending results of the drill holes, the success of the exploration program, the impressive results of the drill campaign, the ability of exploration activities (including drilling) to accurately predict mineralization, future drill programs and high-priority targets, our timing and ability to receive assay results, the reliability of historical information that cannot be independently verified by Sun Summit, interests in the JD Project, errors in geological modelling, and the adjacent properties having any significance to the projects in which Sun Summit has an interest. There is significant risk that the forward-looking statements will not prove to be accurate, that the management’s assumptions may not be correct and that actual results may differ materially from such forward-looking statements. These forward-looking statements are based on a number of assumptions which may prove to be incorrect which, without limiting the generality of the following, include: the Company’s ability to obtain assay results for the completed drill program; the anticipated results varying from current indications, including the already released drill results; risks inherent in exploration activities; volatility and sensitivity to market prices; volatility and sensitivity to capital market fluctuations; and fluctuations in metal prices. Accordingly, readers should not place undue reliance on the forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof or the dates specifically referenced in this news release, where applicable. Except as required by applicable securities laws and regulation, Sun Summit disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. All forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/271649

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./

Quimbaya Gold Inc. (‘Quimbaya’ or the ‘Company’) (CSE: QIM,OTC:QIMGF) (OTCQB: QIMGF) (FSE: K05) is pleased to announce that it has entered into an agreement with Stifel Canada to act as sole underwriter and bookrunner (the ‘Underwriter’), in connection with a ‘bought deal’ private placement of 14,300,000 units of the Company  (the ‘LIFE Units’) at a price of C$0.70 per LIFE Unit (the ‘Offering Price’) for aggregate gross proceeds of C$10,010,000 (the ‘Offering’), with the LIFE Units to be issued pursuant to the Listed Issuer Financing Exemption (as defined below). 

The Company has granted to the Underwriter an option, exercisable up to 48 hours prior to the closing date, to purchase for resale up to an additional 15% of LIFE Units at the Offering Price for additional gross proceeds of up to C$1,501,500

Each LIFE Unit will consist of one common share (a ‘Common Share‘) and one-half (½) of one Common Share purchase warrant (each whole warrant, a ‘Warrant‘) of the Company. Each Warrant will be exercisable to acquire one Common Share for a period of 36 months following the closing date of the Offering at an exercise price of C$1.00 per common share.

The net proceeds from the Offering are expected to be used to advance the Company’s exploration programs, including drilling at the Tahami South project and follow-up work on regional copper-gold and gold targets, as well as for general working capital.

Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 – Prospectus Exemptions (‘NI 45-106‘), the LIFE Units will be offered for sale to purchasers resident in Canada other than Quebec and/or other qualifying jurisdictions pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the ‘Listed Issuer Financing Exemption‘). Because the Offering is being completed pursuant to the Listed Issuer Financing Exemption, the LIFE Units issued pursuant to the Offering will not be subject to a hold period pursuant to applicable Canadian securities laws. There is an offering document related to the Offering that can be accessed under the Company’s issuer profile on SEDAR+ at www.sedarplus.ca and on the Company’s website at quimbayagold.com. Prospective investors should read the offering document before making an investment decision.

The Offering is scheduled to close on or about November 4, 2025 (the ‘Closing Date‘) and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and other approvals including the acceptance of the Canadian Securities Exchange.

The securities referred to in this news release have not been and will not be registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act‘), or any state securities laws and may not be offered or sold within the United States or to, or for the account or benefit of, ‘U.S. Persons’ (as such term is defined in Regulation S under the U.S. Securities Act) absent such registration or an applicable exemption from the registration requirements of the U.S. Securities Act. This news release does not constitute an offer for sale of securities for sale, nor a solicitation for offers to buy any securities. Any public offering of securities in the United States must be made by means of a prospectus containing detailed information about the company and management, as well as financial statements.

About Quimbaya 

Quimbaya aims to discover gold resources through exploration and acquisition of mining properties in the prolific gold mining districts of Colombia. Managed by an experienced team in the mining sector, Quimbaya is focused on three projects in the regions of Segovia (Tahami Project), Puerto Berrio (Berrio Project), and Abejorral (Maitamac Project), all located in Antioquia Province, Colombia.

Quimbaya Gold Inc.

Follow on X @quimbayagoldinc
Follow on LinkedIn @quimbayagold
Follow on YouTube @quimbayagoldinc
Follow on Instagram @quimbayagoldinc
Follow on Facebook @quimbayagoldinc

Cautionary Statements

Certain statements contained in this press release constitute ‘forward-looking information’ as that term is defined in applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information. Generally, but not always, forward-looking statements and information can be identified by the use of forward-looking terminology such as ‘intends’, ‘expects’ or ‘anticipates’, or variations of such words and phrases or statements that certain actions, events or results ‘may’, ‘could’, ‘should’, ‘would’ or ‘occur’. Forward-looking statements herein include statements and information regarding the closing of the Offering, Offering’s intended use of proceeds, any exercise of Warrants, the future plans for the Company, including any expectations of growth or market momentum, future expectations for the gold sector generally, the Colombian gold sector more particularly, or how global or local market trends may affect the Company, intended exploration on any of the Company’s properties and any results thereof, the strength of the Company’s mineral property portfolio, the potential discovery and potential size of the discovery of minerals on any property of the Company’s, including Tahami South, the aims and goals of the Company, and other forward-looking information. Forward-looking information by its nature is based on assumptions and involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Quimbaya to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. These assumptions include, but are not limited to, that the Company’s exploration and other activities will proceed as expected. The future outcomes that relate to forward-looking statements may be influenced by many factors, including but not limited to: future planned development and other activities on the Company’s mineral properties; an inability to finance the Company; obtaining required permitting on the Company’s mineral properties in a timely manner; any adverse changes to the planned operations of the Company’s mineral properties; failure by the Company for any reason to undertake expected exploration programs; achieving and maintaining favourable relationships with local communities; mineral exploration results that are poorer or better than expected; prices for gold remaining as expected; currency exchange rates remaining as expected; availability of funds for the Company’s projects; prices for energy inputs, labour, materials, supplies and services (including transportation); no labour-related disruptions; no unplanned delays or interruptions in scheduled construction and production; all necessary permits, licenses and regulatory approvals are received in a timely manner; the Offering proceeds being received as anticipated; all requisite regulatory and stock exchange approvals for the Offering are obtained in a timely fashion; investor participation in the Offering; and the Company’s ability to comply with environmental, health and safety laws. Although Quimbaya’s management believes that the assumptions made and the expectations represented by such information are reasonable, there can be no assurance that the forward-looking information will prove to be accurate. Furthermore, should one or more of the risks, uncertainties or other factors materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in forward-looking statements or information. Readers are cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking information contained in this news release is expressly qualified by this cautionary statement. The forward-looking information contained in this news release represents the expectations of Quimbaya as of the date of this news release and, accordingly, is subject to change after such date. Except as required by law, Quimbaya does not expect to update forward-looking statements and information continually as conditions change.

SOURCE Quimbaya Gold Inc.

View original content: http://www.newswire.ca/en/releases/archive/October2025/23/c7762.html

News Provided by Canada Newswire via QuoteMedia

This post appeared first on investingnews.com

Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the biotech sector is home to companies pursuing cutting-edge therapies and medical technologies.

Read on to learn what’s been driving these Canadian biotech firms.

1. Eupraxia Pharmaceuticals (TSX:EPRX)

Year-on-year gain: 141.23 percent
Market cap: C$410.85 million
Share price: C$8.25

Eupraxia Pharmaceuticals is developing clinical candidates that employ its DiffuSphere technology, which delivers treatments to the targeted tissues.

The company’s candidates are currently EP-104GI for eosinophilic esophagitis and EP-104IAR for knee osteoarthritis, and it is exploring the use of its technology for other active compounds as well.

Eupraxia added EP-104GI to its pipeline through its acquisition of EpiPharma Therapeutics in late 2023. The company has continued to advance the treatment through clinical trials in 2025 and released multiple rounds of positive data from its Phase 1b/2a trial cohorts.

In July, Eupraxia dosed its first patient after advancing its investigation to Phase 2b trials based on safety and efficacy data from the earlier Phase 2a patient cohorts. Top-line results from the Phase 2b study are anticipated in the second half of 2026.

In September, the company shared data from the highest-dose cohort of the still ongoing Phase 1b/2a trials, reporting that the group saw the largest improvements so far.

2. Bright Minds Biosciences (CSE:DRUG)

Year-on-year gain: 103.17 percent
Market cap: C$683.67 million
Share price: C$92.95

Bright Minds Biosciences is developing novel serotonin agonists targeting neurocircuit abnormalities linked to neuropsychiatric disorders and epilepsy, designing next-generation treatments that aim to retain the therapeutic benefits of psychedelics while minimizing side effects.

Its lead candidate, BMB-101, a selective 5-HT2C receptor agonist, has shown encouraging preclinical efficacy by stopping seizures in an epilepsy mouse model, evaluated jointly with Firefly Neuroscience (NASDAQ:AIFF).

The company’s stock surged nearly 1,500 percent in October 2024 following H. Lundbeck’s acquisition announcement of a competitor focused on similar targets. Strengthening its epilepsy expertise, Bright Minds expanded its scientific advisory board in early 2025 by adding five leaders in the field.

Ongoing clinical progress and strategic growth initiatives position Bright Minds as a promising contender in the neuropsychiatric treatment landscape.

3. Hemostemix (TSXV:HEM)

Year-on-year gain: 31.25 percent
Market cap: C$18.40 million
Share price: C$0.11

Hemostemix is a clinical-stage biotech company focused on developing autologous stem cell therapies, meaning the treatments use a patient’s own cells to theoretically enhance safety and efficacy.

Its main product, ACP-01, is an autologous cell therapy designed to promote tissue repair and regeneration in areas affected by diseases, including a range of heart diseases.

The company announced its first advanced sales orders for ACP-01 in Q1 2025 and has been working to expand internationally and attract new investment.

Hemostemix secured the regulatory green light for commercial sales in Florida after the state passed Senate Bill 1768. The bill creates a framework in which healthcare providers can administer stem cell therapies that had not yet been approved by the US Food and Drug Administration (FDA) but meet the bill’s guidelines.

The company now offers commercial ACP-01 treatments for ischemic pain in the state under the name VesCell, with sales forecasted to reach C$22.5 million in 2026. Operational plans target cash flow positivity by Q4 2026, supported by a growing physician network and commercial pipeline.

Additionally, Hemostemix is currently collaborating with Firefly Neuroscience on a Phase 1 clinical trial of ACP-01 for vascular dementia.

4. NervGen (TSXV:NGEN)

Year-on-year gain: 79.92 percent
Market cap: C$300.97 million
Share price: C$4.39

NervGen is a clinical-stage Canadian biotechnology company that focuses on developing innovative treatments to enable the nervous system to repair itself following damage from injury or disease.

The company’s core technology targets a mechanism that hinders nervous system repair. When the nervous system is damaged, chondroitin sulfate proteoglycans (CSPG) form a “scar.” Initially, CSPGs help contain damage, but their long-term interaction with the PTPσ receptor inhibits repair.

NervGen’s lead drug candidate, NVG-291, is designed to relieve these inhibitory effects to promote nervous system repair. It received fast-track designation from the US FDA.

NervGen is advancing NVG-291 in a Phase 1b/2a clinical trial for spinal cord injury (SCI) and reported positive data from the chronic cohort in June.

NVG-300, a newer preclinical candidate, is being evaluated for ischemic stroke and SCI.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

The NBA asked for this embarrassment.

It was only too happy to jump in bed with legalized gambling, thinking it could take the gaming industry’s money but inoculate itself from its seedy underbelly with a few terse warnings to its players and somber PSAs for fans.

It doesn’t work that way, though. There is always a price to pay for greed and associating with unsavory people, and the NBA’s bill just came due.

Rather than praise for Victor Wembanyama or debates about whether the New York Knicks are the real deal, the NBA woke up Thursday to find itself at the center of a massive betting scandal. Portland Trail Blazers coach Chauncey Billups, Miami Heat guard Terry Rozier and former NBA player Damon Jones all were arrested as part of a yearslong investigation into illegal gambling rings. With ties to the mafia, no less!

Billups was charged in connection with an illegal poker operation while Rozier was accused of manipulating his play during a game to benefit bettors. Jones was charged in both cases.

“We take these allegations with the utmost seriousness,” the NBA said in a statement, “and the integrity of our game remains our top priority.”

Too bad the NBA ceded their right to that high ground long ago.

NBA embraced legalized sports betting

It is true that the NBA does not have a direct role in this scandal. But the enthusiastic embrace of legalized gambling by the league, as well as the NFL, Major League Baseball and just about every other sports organization, has fostered an environment where there are no guardrails.

When the NBA’s own website has a Fantasy page listing “authorized gaming partners and operators,” why should Rozier think it’s a big deal to take a play or two off to help out some bettors? When the NBA allows DraftKings to offer a “promotion” that includes three free months of NBA League Pass, why should Billups question whether it’s a good idea to partake in a shady poker ring?

When the NBA has no problem with its teams having sports books at their arenas, how can it demand that players and coaches keep the gaming industry at arm’s length? When the NBA is sending such mixed messages — problems from gambling are bad! but profits from gambling are good! — why should anyone respect the league’s moral authority?

The league opened the door to this, all of it, and it cannot be surprised or indignant now that it’s gone sideways.

Dangers of sports betting came hand-in-hand with profits

There was a reason every sports entity in the United States resisted any association with legalized gambling for as long as they did. They knew the troubles it would bring because they saw it playing out in real-time overseas. Corrupt people trying to influence games. Gambling addictions. Players being threatened or harassed by bettors and, worse, organized crime.

Ultimately, though, the money was just too good to pass up. NBA commissioner Adam Silver even wrote an op-ed in the New York Times in 2014 encouraging widespread legalization of sports betting. For the good of humanity, of course. People were already gambling, Silver said, so why not bless it?

“I believe that sports betting should be brought out of the underground and into the sunlight where it can be appropriately monitored and regulated,” Silver wrote then.

What’s a little integrity when there are billions in potential profits to be had, right?

By giving their approval to legalized gambling, the NBA and other leagues might as well have handed an arsonist a match.

There is no daylight between gaming and its toxic byproducts, especially when smartphones make irresponsible gambling and abuse of players so easy. Warnings posted in small print, be they in locker rooms or online, are no match for human frailties, temptations and fears, and the NBA owns today’s shame as much as Billups, Rozier, Jones and everyone else who was arrested.

The NBA was well aware of the dangers that come with sports betting and it didn’t care because it wanted the gaming industry’s money more. There’s no more damning indictment than that.

Follow USA TODAY Sports columnist Nancy Armour on social media @nrarmour.

This post appeared first on USA TODAY

INGLEWOOD, CA — In prime time, and in front of a national audience, the Los Angeles Chargers got back in the winner’s column.

Justin Herbert and the Chargers routed the Minnesota Vikings 37-10 to improve to 5-3.

The Chargers took control of the game early. Herbert led the Chargers on three touchdown drives in the first half as team took a commanding 21-3 lead into the locker room at halftime.

The Vikings couldn’t get anything going offensively in the second half and their defense provided little resistance as the Chargers were able to pad their lead.

Carson Wentz threw an interception with 12:02 remaining in the fourth quarter that prompted fans to head for the exits.

USA TODAY Sports was at SoFi Stadium for Thursday night’s Vikings vs. Chargers contest. Here are the winners and losers from the interconference matchup:

Winners

Record-setting Justin Herbert

Herbert completed 18-of-25 passes for 227 yards, to go with three touchdowns and one interception. The quarterback was in command and efficient for most of the contest.

Herbert has 2,146 career completions, the most completions ever by a player in his first six seasons.

Herbert entered Week 8 leading the league in passing yards (1,913) and ranked second in completions (183).

Chargers rushing offense

Th Chargers rushed for a season-high 207 yards.

Running back Kimani Vidal rushed 23 times for 117 yards and one touchdown.  

The Chargers’ season-high output on the ground came without first-round pick RB Omarion Hampton (ankle) who is on injured reserve.

Oronde Gadsden II shines

A week after producing 164 receiving yards, the fourth-most ever by a rookie tight end in a game in NFL history, Oronde Gadsden II tallied five catches for 77 yards and a touchdown.  

The Chargers found themselves a starting tight end for the present and future in Gadsden.

Slot receiver Ladd McConkey had a team-high six catches for 88 yards and a touchdown.  

Chargers D

The Chargers defense held Minnesota to four first downs, 93 yards and three points in the first half. Minnesota’s only touchdown drive came on a short field after a Justin Herbert interception.

The Vikings only gained 164 yards of total offense and went 3-for-11 on third downs.

The Chargers played most of the game without star safety Derwin James who suffered an ankle injury in the first half. No Derwin, no problem: rookie safety RJ Mickens had an interception in the fourth quarter that convinced fans to beat the traffic.

Control-Alt-deleted the Vikings

Chargers standout tackle Joe Alt returned to the lineup after injuring his ankle in Week 4. He had an instant impact as he help stabilize the Chargers O-line.

Thursday best

The Chargers wore their modern throwback all navy uniforms for Thursday’s primetime game. After their popular powder blue unis, it’s probably the second-most visually appealing set they have in the closet.

Losers

The Vikings offense….

Wentz, who had a brace on his left arm, was under duress for much of the game. He was sacked five times and hit eight. He finished with just 144 yards, one touchdown and one interception.  

Wentz was on the injury report with a left shoulder injury leading up to the game. He didn’t look like he was 100%.

Justin Jefferson was a bright spot for the Vikings, as the wide receiver surpassed 8,000 career receiving yards in the matchup. He’s the fastest player to reach 8,000 receiving yards in the Super Bowl era.

…and the Vikings defense…

Vikings CB Isaiah Rodgers had an interception overturned when he didn’t maintain possession of the football on the Chargers first offensive series. It was a huge missed opportunity that would’ve given Minnesota some much-needed momentum.

The Vikings defense gave up 266 yards and three touchdowns in the first half. Minnesota trailed 21-3 at halftime.

The Chargers compiled 419 yards and a season-high 37 points on Minnesota’s defense.

…and the Vikings’ travel itinerary.

The Vikings had international games Week 4 in Ireland and Week 5 in London, followed by a cross country trip to Los Angeles in Week 8. The team played jetlagged on Thursday night.

Follow USA TODAY Sports’ Tyler Dragon on X @TheTylerDragon.

This post appeared first on USA TODAY

  • It’s easy to be cynical in an era of scandal and fake news, but let’s not allow our faith in sports to be fractured just yet.
  • From Shohei Ohtani to Victor Wembanyama to Damar Hamlin, sport still delivers the authentically unexpected, which is something to celebrate.

“This game is rigged.”

“Can’t believe the script had that team winning.”

“Player X is freezing out Player Y because he’s facing him in fantasy this week.”

Most of us have expressed similar sentiments over the years about the sports we watch. In jest.

But Thursday’s shocking revelation that the FBI indicted more than 30 people allegedly linked to a gambling scandal tied to the NBA served to do exactly what pro sports leagues used to fear about any association with betting: rocking the public’s confidence in the integrity of the sports it consumes.

Should we be all that surprised? Really?

Warning alarms have blared since 2018, when the Supreme Court loosened regulations on sports wagering – opening the industry to states far afield from the formerly singular legal sports betting bastion that is Las Vegas. It wasn’t long after that when pro leagues like the NFL began doing what had previously been unthinkable (and taboo) − partnering with betting sites like FanDuel and DraftKings and even allowing sportsbooks to advertise in conjunction with their most premium content: games.

For years, we’ve been trying to parse authentic news from fake, while elected officials – and apparently even Justice Department lawyers at this point – wantonly lie. Many of us have become increasingly desensitized to it. Others actually embrace it.

How are we supposed to know if a pro player is shaving points? Or trafficking insider injury information? It’s not like players across the pro sports spectrum haven’t incurred suspensions in recent years for myriad violations, including betting on games involving their teams. It happens, the respective commissioner touts his league’s gambling guardrails, and everyone basically moves on.

Now the FBI, at a time when its own credibility is under fire, has stepped in to throw a fragmentary grenade into the NBA’s operation. Yet how much will fans care what Damon Jones or Miami Heat guard Terry Rozier or Portland Trail Blazers coach Chauncey Billups purportedly did a week from now? Or even tomorrow? How long before Adam Silver, if he wanted, could hire Vince McMahon as a creative consultant, and no one would blink? And what does it all matter if there’s a metaverse where the New York Jets are the babyface dynasty while the Kansas City Chiefs are the weekly tomato cans?

Easy as it is to be cynical, let’s not allow our faith in sports to be irreparably fractured just yet. There are too many talented athletes working too hard for championship glory – much less simply putting food on the table – and have too much integrity and honor to believe this is all a systemic ruse. (Not for nothing, there are also far too many incapable of keeping a secret this big for us to begin dismissing the veracity of what we see from the couch, press box, upper deck or sideline.)

And while LeBron James has somehow exceeded all the hype that’s been heaped on him for more than a quarter-century – even if Jones apparently profited from knowing how healthy he was – leagues that aren’t actually scripted had no room for would-be leading men like Tim Tebow, Johnny Manziel, Markelle Fultz or Darko Miličić, none lasting despite apparently emanating from central casting.

We should feel comforted that Dwayne “The Rock” Johnson was (is?) nearly incomparable as a professional wrestler but not good enough to play in the NFL − and apparently doesn’t have sufficient business acumen beyond making movies and tequila to make the UFL anything more than the fringe football league its forebears have always been.

Sports never have been, nor will be, a pure meritocracy – contracts, public relations, personalities and the like perpetually exert varying influences. Yet so much of the unparalleled excellence and unimaginable tragedy – not to mention the mundane Week 8 NFL game or Tuesday night NBA contest – are too compelling to be authored by some athletic puppet master. Or sullied by shysters. Not when you see what Shohei Ohtani and George Springer just managed in order to create their World Series matchup. Not when you see the New York Giants find a way to lose an 18-point lead in the final six minutes of a game. Not when you see a 7-foot-5, 245-pound player like Victor Wembanyama run the break … unless he decides to pull up and pop a three. Not when Damar Hamlin nearly dies on a football field before he and his career are revived.

Don’t tell me those moments were or could be orchestrated. Our sports aren’t the WWE writ large (not that wrestling’s ardent fans would care).

May they never be.

This post appeared first on USA TODAY

TORONTO — The Los Angeles Dodgers will be without left-handed reliever Alex Vesia for at least the first two games of the World Series after the club announced that he and his wife were dealing with a “deeply personal family matter.’

Vesia and his wife, Kayla, have been expecting their first child.

“The entire Dodgers organization is sending our thoughts to the Vesia family,’ the Dodgers said in a statement, “and we will provide an update at a later date.’

The Dodgers now have the option, according to an MLB official, of placing Vesia on the “family medical emergency list.’ If Vesia is placed on leave, he would be required to stay for a minimum of three days and a maximum of seven days.

Vesia, who has pitched for the Dodgers since 2021, has been one of their valuable left-handed relievers. He pitched in 68 games during the regular season with a 3.02 ERA and five saves, and appeared in seven of the Dodgers’ 11 postseason games, yielding three hits and striking out four in 4 ⅔ innings.

Veteran reliever Tanner Scott could replace Vesia on the roster. Scott, who signed a four-year, $72 million contract last winter, struggled during the season and lost his closer’s job to Roki Sasaki. He did not pitch the first round of the postseason against the Cincinnati Reds and had been left off the postseason roster the last two rounds after undergoing an abscess incision prodecdure on his lower body.

“I think right now, we’re in the mode of trying to understand the process, the rules, a way that we could sort of try to navigate the roster,” Dodgers manager Dave Roberts said. “So I think we have a little bit of time (10 a.m. ET, Friday)  to finalize our roster. But, yeah, we’re going through the process of trying to backfill his spot on the roster. …

“Honestly, I think we’re just going day-to-day with really no expectations.’’

This post appeared first on USA TODAY

If there was ever a day for Amazon Prime announcer Al Michaels to avoid mentioning sports betting lines for a ‘Thursday Night Football’ game, it would have been Oct. 23.

Hours after the NBA was rocked by a massive sports betting scandal, Michaels was on air discussing the gambling implications of a field goal attempt in the final minutes of the Los Angeles Chargers vs. Minnesota Vikings game.

‘You know, occasionally, a game like this, you think it is over, but it’s not quite over,’ Michaels said, seemingly referencing the game’s over/under line. ‘You know what I mean? I’ll be punished again – what can I tell you? It’s close to being over. I don’t want to call it ‘over’ with three minutes to go.’

The pregame over/under line for the Chargers’ win on Oct. 23 was set at 44.5 points. Michaels started referring to the line in the final three minutes of the game as the Chargers played out their final drive with 44 total points on the board.

‘Sometimes you never know when that half will destroy you,’ Michaels said, referencing the 0.5 points still necessary at that point of the game for an ‘over’ bet to hit.

When Chargers kicker Cameron Dicker lined up for a 45-yard field goal attempt moments later, Michaels returned to referencing the betting line.

‘Meanwhile, you have a 45-yard attempt, which will draw a little interest,’ he said.

Dicker knocked down the 45-yarder, leading to Michaels’ final betting-related comment of the night:

‘And there it is,’ he said as the ball sailed through the uprights. ‘Now you can say it is ‘over.”

This post appeared first on USA TODAY